Page 30 - Breakthrough Device News Today

/PRNewswire/ -- The European Investment Bank (EIB) has awarded a €7.5 million loan to Diadem Srl, a company developing the first blood-based prognostic test...

According to Fact MR’s recent market research, sales of Absorbable Surgical Suture to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provid...

/PRNewswire/ -- The European Investment Bank (EIB) has awarded a €7.5 million loan to Diadem Srl, a company developing the first blood-based prognostic test...

European Investment Bank to Provide a €7.5 Million Loan to Support Further Research and Development of Diadem's AlzoSure® Predict Blood Test for Alzheimer's Disease - read this article along with other careers information, tips and advice on BioSpace

PTSD, or post-traumatic stress disorder, doesn't discriminate. It affects about 15 million adults in the U.S. each year.

/PRNewswire/ -- The "Lithotripsy Devices Market Insights, Competitive Landscape and Market Forecast-2026" report has been added to ResearchAndMarkets.coms...

HEIDELBERG, GERMANY / ACCESSWIRE / February 22, 2022 / Heidelberg-based Precisis GmbH has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its EASEE brain

Investegate announcements from PRECISIS GmbH, Minimally Invasive Epilepsy Treatment EASEE Receives FDA Breakthrough Device Designation

Minimally Invasive Epilepsy Treatment EASEE Receives FDA Breakthrough Device Designation - read this article along with other careers information, tips and advice on BioSpace

SAN DIEGO, Feb. 14, 2022 /PRNewswire/ -- Aethlon Medical, Inc. , a company developing medical technology to treat cancer and life-threatening infectious diseases, today reported financial... | February 14, 2022